ArticleBMJ open2025
Association between anti-Mullerian hormone levels and age in women with endometriosis: insights from a population-based study.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evaluation of angiopoietin-like protein 4 levels in patients with endometriosis.Journal of the Turkish German Gynecological Association · 2026Article
- Risk factors for a marked decline in anti-Müllerian hormone after minimally invasive ovarian cystectomy: A retrospective cohort study.Medicine · 2026Article
- Interleukin-6 and hormonal biomarker profiles in Moroccan women with endometriosis.Obstetrics & gynecology science · 2026Article
- Anti-Müllerian hormone decreased in women with superficial peritoneal endometriosis and associated with an elevated inflammatory profile.Reproduction & fertility · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile previous studies have shown an association between anti-Mullerian hormone (AMH) levels and endometriosis, there are limited data on the relationship between AMH levels and age among women with endometriosis.
objectivesThe present study aimed to investigate the associations between age and AMH levels in women with and without endometriosis. DESIGN AND
settingA cross-sectional, population-based study using data from the ongoing Tehran Lipid and Glucose Study.
participantsA total of 1005 eligible reproductive-age women were selected. These participants were categorised into two groups: women with confirmed endometriosis (n=305) and controls (n=700).
interventionsNone. OUTCOME MEASURES: Association between AMH levels and age among women with endometriosis and healthy controls, using linear, quadratic and segmented regression analyses.
resultsA total of 1005 women aged 18-48 years participated in the study, including 305 (30.3%) with endometriosis and 700 (69.7%) healthy controls. Women with endometriosis had significantly lower AMH levels compared with healthy controls (1.99±1.42 vs 2.30±1.61 ng/mL; p=0.029). In healthy controls, an increase of 1 year was associated with -0.15 ng/mL of AMH (95% CI: -0.17 to -0.14). Segmented regression identified a threshold at 27 years (1.92), with a sharper decline below this age (slope: -0.35, 95% CI: -0.47 to -0.23; p<0.001) and a more gradual decline beyond it (slope: -0.12, 95% CI: -0.14 to -0.10; p<0.001). In women with endometriosis, AMH levels also declined with age (slope: -0.16, 95% CI: -0.17 to -0.14; p<0.001), with no significant threshold observed.
conclusionOur study showed that women with endometriosis had significantly lower AMH levels compared with healthy controls and did not demonstrate the age-related threshold observed in the control group, where AMH levels declined more sharply before 27 years of age. These findings suggest that endometriosis may alter the typical pattern of AMH, indicating that clinicians should interpret AMH levels with caution in this population. Further research is needed to validate these results in other populations and explore alternative biomarkers or strategies for more accurately assessing ovarian reserve in women with endometriosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.